New lung cancer drug combination treats up to 25% of resistant cases

Scientists at Massachusetts General Hospital found that more than half of patients with two forms of treatment resistance saw their lung tumors shrink with a new pairing of targeted drugs.

from Health News | Mail Online https://ift.tt/2I190md